NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Strongbridge Biopharma plc (NASDAQ: SBBP)

 
SBBP Technical Analysis
5
As on 5th Oct 2021 SBBP STOCK Price closed @ 2.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.63 & Strong Sell for SHORT-TERM with Stoploss of 2.39 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SBBPSTOCK Price

Open 1.96 Change Price %
High 2.06 1 Day 0.03 1.52
Low 1.95 1 Week -0.09 -4.31
Close 2.00 1 Month -0.15 -6.98
Volume 684684 1 Year -0.06 -2.91
52 Week High 3.96 | 52 Week Low 1.89
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 141.95 -3.22%
VRPX 0.57 -3.39%
SMCI 33.15 11.62%
LMDX 0.02 0.00%
QUBT 6.10 28.15%
TSLA 352.56 3.80%
PONO 1.72 2.38%
TELL 1.00 0.00%
FLEX 41.30 1.90%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
AMPGW 0.03 200.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
QMCO 9.13 127.11%
BCAC 22.71 125.30%
 
NASDAQ USA Top Losers Stocks
SNAXW 0.00 -100.00%
HOFVW 0.00 -100.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
MILEW 0.06 -53.85%
OCAXW 0.01 -50.00%
LOTZW 0.01 -50.00%
 
 
SBBP
Daily Charts
SBBP
Intraday Charts
Whats New @
Bazaartrend
SBBP
Free Analysis
 
SBBP Important Levels Intraday
RESISTANCE2.21
RESISTANCE2.14
RESISTANCE2.10
RESISTANCE2.06
SUPPORT1.94
SUPPORT1.90
SUPPORT1.86
SUPPORT1.79
 
SBBP Forecast November 2024
4th UP Forecast3.73
3rd UP Forecast3.18
2nd UP Forecast2.83
1st UP Forecast2.49
1st DOWN Forecast1.51
2nd DOWN Forecast1.17
3rd DOWN Forecast0.82
4th DOWN Forecast0.27
 
SBBP Weekly Forecast
4th UP Forecast2.44
3rd UP Forecast2.30
2nd UP Forecast2.21
1st UP Forecast2.13
1st DOWN Forecast1.87
2nd DOWN Forecast1.79
3rd DOWN Forecast1.70
4th DOWN Forecast1.56
 
SBBP Forecast2024
4th UP Forecast6.64
3rd UP Forecast5.15
2nd UP Forecast4.23
1st UP Forecast3.31
1st DOWN Forecast0.69
2nd DOWN Forecast-0.23
3rd DOWN Forecast-1.15
4th DOWN Forecast-2.64
 
 
SBBP Other Details
Segment EQ
Market Capital 135658000.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
SBBP Address
SBBP
 
SBBP Latest News
 
Your Comments and Response on Strongbridge Biopharma plc
 
SBBP Business Profile
As of October 5, 2021, Strongbridge Biopharma plc was acquired by Xeris Pharmaceuticals, Inc. Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs in the United States. The company offers Keveyis, an oral carbonic anhydrase inhibitor to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in Phase III clinical trials for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that has completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania. Address: 900 Northbrook Drive, Trevose, PA, United States, 19053
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service